tiprankstipranks
Trending News
More News >
Kane Biotech Inc (TSE:KNE)
:KNE
Canadian Market

Kane Biotech (KNE) Cash flow

Compare
1 Followers

Kane Biotech Cash Flow

TSE:KNE's free cash flow for Q3 2025 was C$-698.22K. For the 2025 fiscal year, TSE:KNE's free cash flow was decreased by C$-905.25K and operating cash flow was C$-698.22K. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
C$ -4.11MC$ -3.22MC$ -3.04MC$ -2.29MC$ -3.94M
Investing Cash Flow
C$ 10.27MC$ -116.14KC$ -107.55KC$ -373.55KC$ -166.11K
Financing Cash Flow
C$ -7.69MC$ 2.98MC$ 3.10MC$ 2.81MC$ 4.28M
End Cash Position
C$ 358.81KC$ 749.25KC$ 1.10MC$ 1.15MC$ 1.01M
Free Cash Flow
C$ -4.14MC$ -3.23MC$ -3.13MC$ -2.64MC$ -4.07M
Currency in CAD

Kane Biotech Cash Flow